# FRUZAQLA
> **NDA217564** · New Drug Application · Sponsor: TAKEDA PHARMS USA · Approved 2023-11-08
## Drug
- **FDA Application Number:** NDA217564
- **Application type:** New Drug Application
- **Brand name:** FRUZAQLA
- **Generic name:** FRUQUINTINIB
- **Active ingredients:** FRUQUINTINIB
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** TAKEDA PHARMS USA
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2023-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217564)
---
*MORVS · CC0 1.0*